PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

CUSIP: 717224109

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
18,335,192
Share change
-145,037
Total reported value
$84,333,772
Put/Call ratio
105%
Price per share
$4.60
Number of holders
59
Value change
+$85,004
Number of buys
35
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) as of Q2 2020

As of 30 Jun 2020, PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) was held by 59 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,335,192 shares. The largest 10 holders included NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, Johnson & Johnson Innovation - JJDC, Inc., Rock Springs Capital Management LP, BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, DAFNA Capital Management LLC, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 59 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.